-
Signature
-
/s/ Michelle Webb, Attorney-in-fact
-
Issuer symbol
-
ACVA
-
Transactions as of
-
02 Jan 2024
-
Net transactions value
-
-$3,210,356
-
Form type
-
4
-
Filing time
-
04 Jan 2024, 18:50:56 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACVA |
Class A Common Stock |
Options Exercise |
|
+52,849 |
+26% |
|
252,630 |
02 Jan 2024 |
Direct |
F1, F2 |
| transaction |
ACVA |
Class A Common Stock |
Sale |
$786,922 |
-52,849 |
-21% |
$14.89 |
199,781 |
02 Jan 2024 |
Direct |
F3, F4 |
| transaction |
ACVA |
Class A Common Stock |
Options Exercise |
|
+76,703 |
+38% |
|
276,484 |
02 Jan 2024 |
Direct |
F1 |
| transaction |
ACVA |
Class A Common Stock |
Sale |
$1,142,108 |
-76,703 |
-28% |
$14.89 |
199,781 |
02 Jan 2024 |
Direct |
F3, F4 |
| transaction |
ACVA |
Class A Common Stock |
Tax liability |
$45,712 |
-3,070 |
-1.5% |
$14.89 |
196,711 |
02 Jan 2024 |
Direct |
F5 |
| transaction |
ACVA |
Class A Common Stock |
Tax liability |
$77,205 |
-5,185 |
-2.6% |
$14.89 |
191,526 |
02 Jan 2024 |
Direct |
F5 |
| transaction |
ACVA |
Class A Common Stock |
Options Exercise |
|
+48,297 |
+25% |
|
239,823 |
03 Jan 2024 |
Direct |
F1 |
| transaction |
ACVA |
Class A Common Stock |
Sale |
$696,926 |
-48,297 |
-20% |
$14.43 |
191,526 |
03 Jan 2024 |
Direct |
F3, F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ACVA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-52,849 |
-34% |
$0.000000 |
103,063 |
02 Jan 2024 |
Class B Common Stock |
52,849 |
$0.6600 |
Direct |
F7 |
| transaction |
ACVA |
Class B Common Stock |
Options Exercise |
$34,880 |
+52,849 |
+42% |
$0.6600* |
180,165 |
02 Jan 2024 |
Class A Common Stock |
52,849 |
|
Direct |
F1, F8 |
| transaction |
ACVA |
Class B Common Stock |
Conversion of derivative security |
$0 |
-52,849 |
-29% |
$0.000000 |
127,316 |
02 Jan 2024 |
Class A Common Stock |
52,849 |
|
Direct |
F1, F8 |
| transaction |
ACVA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-76,703 |
-44% |
$0.000000 |
98,297 |
02 Jan 2024 |
Class B Common Stock |
76,703 |
$2.44 |
Direct |
F9 |
| transaction |
ACVA |
Class B Common Stock |
Options Exercise |
$187,155 |
+76,703 |
+60% |
$2.44* |
204,019 |
02 Jan 2024 |
Class A Common Stock |
76,703 |
|
Direct |
F1, F8 |
| transaction |
ACVA |
Class B Common Stock |
Conversion of derivative security |
$0 |
-76,703 |
-38% |
$0.000000 |
127,316 |
02 Jan 2024 |
Class A Common Stock |
76,703 |
|
Direct |
F1, F8 |
| transaction |
ACVA |
Class B Common Stock |
Tax liability |
$104,438 |
-7,014 |
-5.5% |
$14.89 |
120,302 |
02 Jan 2024 |
Class A Common Stock |
7,014 |
|
Direct |
F1, F8 |
| transaction |
ACVA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$696,926 |
-48,297 |
-49% |
$14.43 |
50,000 |
03 Jan 2024 |
Class B Common Stock |
48,297 |
$2.44 |
Direct |
F9 |
| transaction |
ACVA |
Class B Common Stock |
Options Exercise |
$117,845 |
+48,297 |
+40% |
$2.44* |
168,599 |
03 Jan 2024 |
Class A Common Stock |
48,297 |
|
Direct |
F1, F8 |
| transaction |
ACVA |
Class B Common Stock |
Conversion of derivative security |
$0 |
-48,297 |
-29% |
$0.000000 |
120,302 |
03 Jan 2024 |
Class A Common Stock |
48,297 |
|
Direct |
F1, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: